This is the authors' abstract. We don't add key points for this paper.
Our results suggest that the rate of functional decline accelerates along the AD continuum, as shown by steeper rates of decline in each successive NIA-AA clinical stage. These results imply that incremental changes in function are a meaningful measure for early disease monitoring. Combined with the low-cost assessment, this advocates the use of these functional questionnaires for capturing the effects of early AD-related cognitive decline on daily life.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dubbelman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: